In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, CTOs, VPs of Product Development, heads of Healthcare Verticals, and commercial directors from digital payment solution providers, fintech firms, healthcare IT suppliers, and payment gateway service providers were examples of supply-side sources. Chief financial officers, revenue cycle directors, directors of health information technology, procurement leads from hospital systems, integrated delivery networks (IDNs), specialty clinics, health insurance payers, and pharmacy benefit managers were examples of demand-side sources. Market segmentation, product roadmap dates, enterprise adoption trends, price models, API integration issues, and reimbursement processing workflows were all corroborated by primary research.
Primary Respondent Breakdown:
By Designation: C-level Executives (28%), Director Level (32%), Vice Presidents (22%), Others (18%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Revenue mapping and transaction volume analysis were used to determine the global market valuation. The methodology comprised:
Finding more than fifty major suppliers of solutions in North America, Europe, Asia-Pacific, and Latin America
Product mapping between revenue cycle management systems, payment gateway solutions, payment processing services, and merchant services tailored to the healthcare industry Examination of annual revenues for healthcare digital payment portfolios, both reported and modeled
Coverage of suppliers accounting for 75–80% of the worldwide market in 2024 Extrapolation for segment-specific valuations for Solutions vs. Services, Cloud vs. On-Premise, and SME vs. Large Enterprise installations utilizing top-down (provider revenue validation) and bottom-up (transaction volume × average transaction value × take rate by nation) methodologies